These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 105418)

  • 1. Developmental staging and thalidomide teratogenicity in the green monkey (Cercopithecus aethiops).
    Hendrickx AG; Sawyer RH
    Teratology; 1978 Dec; 18(3):393-404. PubMed ID: 105418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal malformations and early embryonic gene expression response in cynomolgus monkeys maternally exposed to thalidomide.
    Ema M; Ise R; Kato H; Oneda S; Hirose A; Hirata-Koizumi M; Singh AV; Knudsen TB; Ihara T
    Reprod Toxicol; 2010 Jan; 29(1):49-56. PubMed ID: 19751816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporomandibular malformations in the bonnet monkey (Macaca radiata) fetus following maternal ingestion of thalidomide.
    Newman LM; Hendrickx AG
    J Craniofac Genet Dev Biol; 1985; 5(2):147-57. PubMed ID: 4019728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embryotoxicity and teratogenicity of thalidomide in rats.
    Parkhie M; Webb M
    Teratology; 1983 Jun; 27(3):327-32. PubMed ID: 6410529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Theoretical and applied aspects of experimental teratology].
    Dyban AP
    Ontogenez; 1977; 8(6):582-98. PubMed ID: 414184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of thalidomide in chicken embryos.
    Stephens TD
    Birth Defects Res A Clin Mol Teratol; 2009 Aug; 85(8):725-31. PubMed ID: 19645049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The teratogenic activity of a thalidomide analogue, EM 12 in rabbits, rats, and monkeys.
    Schumacher HJ; Terapane J; Jordan RL; Wilson JG
    Teratology; 1972 Apr; 5(2):233-40. PubMed ID: 4623448
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of thalidomide teratogenicity by acetylsalicylic acid: evidence for prostaglandin H synthase-catalyzed bioactivation of thalidomide to a teratogenic reactive intermediate.
    Arlen RR; Wells PG
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1649-58. PubMed ID: 8667234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limb reduction anomalies induced in the marmoset by thalidomide.
    Hamilton WJ; Poswillo DE
    J Anat; 1972 Apr; 111(Pt 3):505-6. PubMed ID: 4627159
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonteratogenicity of a structural analog of thalidomide in pregnant baboons (Papio cynocephalus).
    Hendrickx AG; Helm FC
    Teratology; 1980 Oct; 22(2):179-82. PubMed ID: 7444806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A metabolite of a structural analog of thalidomide lacks teratogenic effect in pregnant rhesus monkeys.
    Scott WJ; Wilson JG; Helm FC
    Teratology; 1980 Oct; 22(2):183-5. PubMed ID: 7444807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teratogenic effects of chlorambucil on in vivo and in vitro organogenesis in mice.
    Salder TW; Kochhar DM
    Teratology; 1975 Aug; 12(1):71-8. PubMed ID: 1172300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity.
    Parman T; Wiley MJ; Wells PG
    Nat Med; 1999 May; 5(5):582-5. PubMed ID: 10229238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single versus multiple dose administration of all-trans-retinoic acid during organogenesis: differential metabolism and transplacental kinetics in rat and rabbit.
    Collins MD; Tzimas G; Bürgin H; Hummler H; Nau H
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):9-18. PubMed ID: 7839374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the developmental toxicity of lenalidomide in rabbits.
    Christian MS; Laskin OL; Sharper V; Hoberman A; Stirling DI; Latriano L
    Birth Defects Res B Dev Reprod Toxicol; 2007 Jun; 80(3):188-207. PubMed ID: 17570132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for teratogenicity of thalidomide using congenic and recombinant inbred rat strains.
    Bílá V; Kren V
    Folia Biol (Praha); 1994; 40(4):161-71. PubMed ID: 7851614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The teratogenic activity of a thalidomide analogus EM12 in rats on a low-zinc diet.
    Jackson AJ; Schumacher HJ
    Teratology; 1979 Jun; 19(3):341-4. PubMed ID: 473085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The teratogenic activity of thalidomide in the rabbit.
    Fabro S; Smith RL
    J Pathol Bacteriol; 1966 Apr; 91(2):511-9. PubMed ID: 4958643
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of the etiology of thalidomide dysmorphogenesis.
    McBride WG
    Teratology; 1976 Aug; 14(1):71-87. PubMed ID: 960013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.